COPD Trial, Recruiting NCT06733662 Sponsor: Kahramanmaraş İstiklal University Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT06733662
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had a confirmed diagnosis of COPD (a chronic lung condition) for at least 6 months
  • People who are admitted to the chest clinic
  • People who have no communication difficulties
  • People who have voluntarily agreed to take part in the study

Who may not be able to join:

  • People whose COPD symptoms are currently flaring up (known as an exacerbation)
  • People who are unable to cooperate due to severe breathlessness
  • People who have a cancer diagnosis (confirm with trial site)
  • People who have a confirmed diagnosis of a psychiatric illness

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 541 447 49 44

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Kahramanmaraş İstiklal University
Registry
ClinicalTrials.gov
Start date
15 August 2024
Est. completion
10 January 2025

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Morisky 8-item Medication Adherence Scale; Morisky 8-item Medication Adherence Scale; Self-care Agency Scale; Self-care Agency Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov